ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
5
views
0
references
Top references
cited by
2
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,001
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Abstract CT326: Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors
Author(s):
LV Sequist
,
P Cassier
,
A. W. Varga
,
J Tabernero
,
JH Schellens
,
J.-P. Delord
,
P LoRusso
,
DR Camidge
,
MH Medina
,
M Schuler
Publication date:
2014
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Karger: Oncology
Data availability:
ScienceOpen disciplines:
Oncology & Radiotherapy
,
Medicine
Comments
Comment on this article
Sign in to comment
Similar content
2,001
A phase I dose escalation study of NVP-BGJ398, a selective pan FGFR inhibitor in genetically preselected advanced solid tumors [Abstract].
Authors:
J Wolf
,
PM LoRusso
,
RD Camidge
A phase I dose escalation study of NVP-BGJ398, a selective pan FGFR inhibitor in genetically preselected advanced solid tumors [Abstract].
Authors:
J Wolf
,
PM LoRusso
,
RD Camidge
Efficacy of BGJ398, a fibroblast growth factor receptor (FGFR) 1–3 inhibitor, in patients (pts) with previously treated advanced/metastatic urothelial carcinoma (mUC) with FGFR3 alterations
Authors:
S.K Pal
,
J.E. Rosenberg
,
B Keam
…
See all similar
Cited by
2
Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies
Authors:
Mohamed Akl
,
Poonam Nagpal
,
Nehad M. Ayoub
…
Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application
Authors:
Young Kwang Chae
,
Keerthi Ranganath
,
Peter Hammerman
…
See all cited by